POMDOCTOR LIMITED American Depositary Shares (POM) - Total Assets
Based on the latest financial reports, POMDOCTOR LIMITED American Depositary Shares (POM) holds total assets worth $46.23 Million USD as of December 2024. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See POMDOCTOR LIMITED American Depositary Sh (POM) net assets for net asset value and shareholders' equity analysis.
POMDOCTOR LIMITED American Depositary Shares - Total Assets Trend (2003–2024)
This chart illustrates how POMDOCTOR LIMITED American Depositary Shares's total assets have evolved over time, based on quarterly financial data.
POMDOCTOR LIMITED American Depositary Shares - Asset Composition Analysis
Current Asset Composition (December 2024)
POMDOCTOR LIMITED American Depositary Shares's total assets of $46.23 Million consist of 81.1% current assets and 18.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 16.6% |
| Accounts Receivable | $14.97 Million | 32.4% |
| Inventory | $9.17 Million | 19.8% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2003–2024)
This chart illustrates how POMDOCTOR LIMITED American Depositary Shares's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see POMDOCTOR LIMITED American Depositary Sh (POM) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: POMDOCTOR LIMITED American Depositary Shares's current assets represent 81.1% of total assets in 2024, an increase from 12.1% in 2003.
- Cash Position: Cash and equivalents constituted 16.6% of total assets in 2024, up from 0.7% in 2003.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 10.0% in 2003.
- Asset Diversification: The largest asset category is accounts receivable at 32.4% of total assets.
POMDOCTOR LIMITED American Depositary Shares Competitors by Total Assets
Key competitors of POMDOCTOR LIMITED American Depositary Shares based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Raia Drogasil S.A
SA:RADL3
|
Brazil | R$25.27 Billion |
|
Empreendimentos Pague Menos S.A
SA:PGMN3
|
Brazil | R$9.81 Billion |
|
d1000 Varejo Farma Participações S.A
SA:DMVF3
|
Brazil | R$1.95 Billion |
|
High Tide Inc
V:HITI
|
Canada | CA$346.42 Million |
|
Yifeng Pharmacy
SHG:603939
|
China | CN¥26.07 Billion |
|
Dashenlin Pharm Grp Co Ltd
SHG:603233
|
China | CN¥26.83 Billion |
|
Laobaixing Pharmacy
SHG:603883
|
China | CN¥19.91 Billion |
|
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A
SHE:301408
|
China | CN¥5.55 Billion |
POMDOCTOR LIMITED American Depositary Shares - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.21 | 0.35 | 0.99 |
| Quick Ratio | 0.16 | 0.27 | 0.99 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-141.65 Million | $-112.58 Million | $-8.00 Million |
POMDOCTOR LIMITED American Depositary Shares - Advanced Valuation Insights
This section examines the relationship between POMDOCTOR LIMITED American Depositary Shares's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.31 |
| Asset Growth Rate (YoY) | -30.3% |
| Total Assets | $46.23 Million |
| Market Capitalization | $14.20 Million USD |
Valuation Analysis
Below Book Valuation: The market values POMDOCTOR LIMITED American Depositary Shares's assets below their book value (0.31x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: POMDOCTOR LIMITED American Depositary Shares's assets decreased by 30.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for POMDOCTOR LIMITED American Depositary Shares (2003–2024)
The table below shows the annual total assets of POMDOCTOR LIMITED American Depositary Shares from 2003 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $46.23 Million | -30.28% |
| 2023-12-31 | $66.31 Million | +36.39% |
| 2022-12-31 | $48.62 Million | +151.76% |
| 2021-12-31 | $19.31 Million | -75.07% |
| 2020-12-31 | $77.47 Million | -98.85% |
| 2019-12-31 | $6.75 Billion | -94.36% |
| 2018-12-31 | $119.67 Billion | +2.54% |
| 2017-12-31 | $116.70 Billion | +1.56% |
| 2016-12-31 | $114.90 Billion | +603.81% |
| 2015-12-31 | $16.33 Billion | +4.21% |
| 2014-12-31 | $15.67 Billion | +5.52% |
| 2013-12-31 | $14.85 Billion | -5.88% |
| 2012-12-31 | $15.78 Billion | +5.81% |
| 2011-12-31 | $14.91 Billion | +418.07% |
| 2010-12-31 | $2.88 Billion | -81.76% |
| 2009-12-31 | $15.78 Billion | -4.22% |
| 2008-12-31 | $16.48 Billion | +9.03% |
| 2007-12-31 | $15.11 Billion | +6.09% |
| 2006-12-31 | $14.24 Billion | +1.61% |
| 2005-12-31 | $14.02 Billion | +5.00% |
| 2004-12-31 | $13.35 Billion | -0.63% |
| 2003-12-31 | $13.43 Billion | -- |
About POMDOCTOR LIMITED American Depositary Shares
Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company's busines… Read more